We are live on ! Find out more
ZJYL

Jin Medical International

2 hedge funds and large institutions have $8.73K invested in Jin Medical International in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.26% less ownership

Funds ownership: 0.26% → 0% (-0.26%)

80% less funds holding

Funds holding: 10 → 2 (-8)

90% less capital invested

Capital invested by funds: $88.6K → $8.73K (-$79.8K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 8

Holders
2
Holders Change
-8
Holders Change %
-80%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ZJYL Hedge Fund Activity: Q1 2026 in Review

2 of the 8,206 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q1 2026, worth a combined $8.73K — down 90% from $88.6K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ZJYL and 0 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Osaic Holdings, adding an estimated $4.44K. The largest seller was Citadel Advisors, exiting entirely with an estimated $25.9K sold.

  • 2 institutional investors held Jin Medical International (ZJYL) as of Q1 2026, down from 10 in Q4 2025.
  • Funds reported $8.73K of Jin Medical International stock for Q1 2026, down 90% quarter-over-quarter.
  • 0 funds opened new Jin Medical International positions in Q1 2026 and 8 closed out, a net change of -8 holders.
  • The largest Jin Medical International buyer in Q1 2026 was Osaic Holdings, an estimated $4.44K added.
  • The largest Jin Medical International seller in Q1 2026 was Citadel Advisors, an estimated $25.9K sold.

Based on aggregated 13F filings for Q1 2026.